STAAR Surgical STAA
STAAR Surgical FY 2022: revenue $284.4M, up 23%; diluted EPS $0.78
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001564590-23-002249
- Document
- 10-K
- Exhibit 10.27
- Material contract
Key figures from this report
These are the numbers STAAR Surgical reported for the year ended Dec 30, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$284.4M+23% from $230.5M in FY 202110-K income statement, on EDGAR
- Net income$38.8M+58% from $24.5M in FY 202110-K income statement, on EDGAR
- Diluted EPS$0.78+56% from $0.50 in FY 202110-K income statement, on EDGAR
- Cash and cash equivalents$86.5M−57% from $199.7M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations$35.7M−19% from $44.0M in FY 202110-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3851 and related industry codes: the same peer list as the financial tables.
- National Vision Holdings EYE public float $1.3B, Jun 28, 2025
- Bausch & Lomb BLCO public float $557M, Jun 30, 2025
- RxSight RXST public float $504M, Jun 30, 2025
- Warby Parker WRBY public float $2.2B, Jun 30, 2025